Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 Sep;96(3):1238–1244. doi: 10.1172/JCI118157

Adenyl cyclase and interleukin 6 are downstream effectors of parathyroid hormone resulting in stimulation of bone resorption.

E M Greenfield 1, S M Shaw 1, S A Gornik 1, M A Banks 1
PMCID: PMC185744  PMID: 7657797

Abstract

Parathyroid hormone and other bone resorptive agents function, at least in part, by inducing osteoblasts to secrete cytokines that stimulate both differentiation and resorptive activity of osteoclasts. We previously identified two potentially important cytokines by demonstrating that parathyroid hormone induces expression by osteoblasts of IL-6 and leukemia inhibitory factor without affecting levels of 14 other cytokines. Although parathyroid hormone activates multiple signal transduction pathways, induction of IL-6 and leukemia inhibitory factor is dependent on activation of adenyl cyclase. This study demonstrates that adenyl cyclase is also required for stimulation of osteoclast activity in cultures containing osteoclasts from rat long bones and UMR106-01 rat osteoblast-like osteosarcoma cells. Since the stimulation by parathyroid hormone of both cytokine production and bone resorption depends on the same signal transduction pathway, we hypothesized that IL-6 might be a downstream effector of parathyroid hormone. We found that addition of exogenous IL-6 mimics the ability of parathyroid hormone to stimulate bone resorption. More importantly, an antibody directed against the IL-6 receptor blocks moderate stimulation of osteoclast activity induced by the hormone. Interestingly, strong stimulation of resorption overcomes this dependence on IL-6. Thus, parathyroid hormone likely induces multiple, redundant cytokines that can overcome the IL-6 requirement associated with moderate stimulation. Taken together with studies showing that many other bone resorptive agents also stimulate IL-6 production, our results suggest that IL-6 may be a downstream effector of these agents as well as of parathyroid hormone.

Full text

PDF
1238

Images in this article

1240Image
on p.1240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Ishimi Y., Takahashi N., Akatsu T., Ozawa H., Yamana H., Yoshiki S., Suda T. A differentiation-inducing factor produced by the osteoblastic cell line MC3T3-E1 stimulates bone resorption by promoting osteoclast formation. J Bone Miner Res. 1988 Dec;3(6):635–645. doi: 10.1002/jbmr.5650030609. [DOI] [PubMed] [Google Scholar]
  2. Abou-Samra A. B., Jüppner H., Force T., Freeman M. W., Kong X. F., Schipani E., Urena P., Richards J., Bonventre J. V., Potts J. T., Jr Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2732–2736. doi: 10.1073/pnas.89.7.2732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abraham D. C., Wadkins C. L., Conaway H. H. Enhancement of fetal rat limb bone resorption by phorbol ester (PMA) and ionophore A-23187. Calcif Tissue Int. 1988 Mar;42(3):191–195. doi: 10.1007/BF02556333. [DOI] [PubMed] [Google Scholar]
  4. Amano S., Hanazawa S., Kawata Y., Ohta K., Kitami H., Kitano S. An assay system utilizing devitalized bone for assessment of differentiation of osteoclast progenitors. J Bone Miner Res. 1992 Mar;7(3):321–328. doi: 10.1002/jbmr.5650070312. [DOI] [PubMed] [Google Scholar]
  5. Athanasou N. A., Quinn J., McGee J. O. Immunocytochemical analysis of the human osteoclast: phenotypic relationship to other marrow-derived cells. Bone Miner. 1988 Mar;3(4):317–333. [PubMed] [Google Scholar]
  6. Barton B. E., Mayer R. IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. J Immunol. 1989 Nov 15;143(10):3211–3216. [PubMed] [Google Scholar]
  7. Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2496–2500. doi: 10.1073/pnas.83.8.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chambers T. J., McSheehy P. M., Thomson B. M., Fuller K. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 1985 Jan;116(1):234–239. doi: 10.1210/endo-116-1-234. [DOI] [PubMed] [Google Scholar]
  9. Chaudhary L. R., Spelsberg T. C., Riggs B. L. Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 beta and tumor necrosis factor-alpha: lack of regulation by 17 beta-estradiol. Endocrinology. 1992 May;130(5):2528–2534. doi: 10.1210/endo.130.5.1572280. [DOI] [PubMed] [Google Scholar]
  10. Clohisy D. R., Vorlicky L., Oegema T. R., Jr, Snover D., Thompson R. C., Jr Histochemical and immunohistochemical characterization of cells constituting the giant cell tumor of bone. Clin Orthop Relat Res. 1993 Feb;(287):259–265. [PubMed] [Google Scholar]
  11. Elias J. A., Tang W., Horowitz M. C. Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology. 1995 Feb;136(2):489–498. doi: 10.1210/endo.136.2.7835281. [DOI] [PubMed] [Google Scholar]
  12. Evely R. S., Bonomo A., Schneider H. G., Moseley J. M., Gallagher J., Martin T. J. Structural requirements for the action of parathyroid hormone-related protein (PTHrP) on bone resorption by isolated osteoclasts. J Bone Miner Res. 1991 Jan;6(1):85–93. doi: 10.1002/jbmr.5650060114. [DOI] [PubMed] [Google Scholar]
  13. Feyen J. H., Elford P., Di Padova F. E., Trechsel U. Interleukin-6 is produced by bone and modulated by parathyroid hormone. J Bone Miner Res. 1989 Aug;4(4):633–638. doi: 10.1002/jbmr.5650040422. [DOI] [PubMed] [Google Scholar]
  14. Fujimori A., Cheng S. L., Avioli L. V., Civitelli R. Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells. Endocrinology. 1991 Jun;128(6):3032–3039. doi: 10.1210/endo-128-6-3032. [DOI] [PubMed] [Google Scholar]
  15. Girasole G., Jilka R. L., Passeri G., Boswell S., Boder G., Williams D. C., Manolagas S. C. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest. 1992 Mar;89(3):883–891. doi: 10.1172/JCI115668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Girasole G., Passeri G., Jilka R. L., Manolagas S. C. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest. 1994 Apr;93(4):1516–1524. doi: 10.1172/JCI117130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Greenfield E. M., Gornik S. A., Horowitz M. C., Donahue H. J., Shaw S. M. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res. 1993 Oct;8(10):1163–1171. doi: 10.1002/jbmr.5650081003. [DOI] [PubMed] [Google Scholar]
  18. Hattersley G., Dorey E., Horton M. A., Chambers T. J. Human macrophage colony-stimulating factor inhibits bone resorption by osteoclasts disaggregated from rat bone. J Cell Physiol. 1988 Oct;137(1):199–203. doi: 10.1002/jcp.1041370125. [DOI] [PubMed] [Google Scholar]
  19. Herrmann-Erlee M. P., Nijweide P. J., van der Meer J. M., Ooms M. A. Action of bPTH and bPTH fragments on embryonic bone in vitro: dissociation of the cyclic AMP and bone resorbing response. Calcif Tissue Int. 1983;35(1):70–77. doi: 10.1007/BF02405009. [DOI] [PubMed] [Google Scholar]
  20. Holt I., Davie M. W., Braidman I. P., Marshall M. J. Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones. Calcif Tissue Int. 1994 Aug;55(2):114–119. doi: 10.1007/BF00297186. [DOI] [PubMed] [Google Scholar]
  21. Horowitz M. C. Cytokines and estrogen in bone: anti-osteoporotic effects. Science. 1993 Apr 30;260(5108):626–627. doi: 10.1126/science.8480174. [DOI] [PubMed] [Google Scholar]
  22. Hoyland J. A., Freemont A. J., Sharpe P. T. Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res. 1994 Jan;9(1):75–80. doi: 10.1002/jbmr.5650090111. [DOI] [PubMed] [Google Scholar]
  23. Ishimi Y., Abe E., Jin C. H., Miyaura C., Hong M. H., Oshida M., Kurosawa H., Yamaguchi Y., Tomida M., Hozumi M. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism. J Cell Physiol. 1992 Jul;152(1):71–78. doi: 10.1002/jcp.1041520110. [DOI] [PubMed] [Google Scholar]
  24. Ishimi Y., Miyaura C., Jin C. H., Akatsu T., Abe E., Nakamura Y., Yamaguchi A., Yoshiki S., Matsuda T., Hirano T. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol. 1990 Nov 15;145(10):3297–3303. [PubMed] [Google Scholar]
  25. Jablonski G., Danielsen C. C., Mosekilde L., Gordeladze J. O. Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption. Calcif Tissue Int. 1994 Oct;55(4):281–287. doi: 10.1007/BF00310407. [DOI] [PubMed] [Google Scholar]
  26. Jilka R. L., Hangoc G., Girasole G., Passeri G., Williams D. C., Abrams J. S., Boyce B., Broxmeyer H., Manolagas S. C. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science. 1992 Jul 3;257(5066):88–91. doi: 10.1126/science.1621100. [DOI] [PubMed] [Google Scholar]
  27. Kaji H., Sugimoto T., Kanatani M., Fukase M. The activation of cAMP-dependent protein kinase is directly linked to the stimulation of bone resorption by parathyroid hormone. Biochem Biophys Res Commun. 1992 Feb 14;182(3):1356–1361. doi: 10.1016/0006-291x(92)91882-q. [DOI] [PubMed] [Google Scholar]
  28. Kishimoto T., Taga T., Akira S. Cytokine signal transduction. Cell. 1994 Jan 28;76(2):253–262. doi: 10.1016/0092-8674(94)90333-6. [DOI] [PubMed] [Google Scholar]
  29. Klein D. C., Raisz L. G. Role of adenosine-3',5'-monophosphate in the hormonal regulation of bone resorption: studies with cultured fetal bone. Endocrinology. 1971 Sep;89(3):818–826. doi: 10.1210/endo-89-3-818. [DOI] [PubMed] [Google Scholar]
  30. Kurihara N., Bertolini D., Suda T., Akiyama Y., Roodman G. D. IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol. 1990 Jun 1;144(11):4226–4230. [PubMed] [Google Scholar]
  31. Lacey D. L., Grosso L. E., Moser S. A., Erdmann J., Tan H. L., Pacifici R., Villareal D. T. IL-1-induced murine osteoblast IL-6 production is mediated by the type 1 IL-1 receptor and is increased by 1,25 dihydroxyvitamin D3. J Clin Invest. 1993 Apr;91(4):1731–1742. doi: 10.1172/JCI116383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Linkhart T. A., Linkhart S. G., MacCharles D. C., Long D. L., Strong D. D. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1. J Bone Miner Res. 1991 Dec;6(12):1285–1294. doi: 10.1002/jbmr.5650061204. [DOI] [PubMed] [Google Scholar]
  33. Littlewood A. J., Russell J., Harvey G. R., Hughes D. E., Russell R. G., Gowen M. The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology. 1991 Sep;129(3):1513–1520. doi: 10.1210/endo-129-3-1513. [DOI] [PubMed] [Google Scholar]
  34. Ljunggren O., Ljunghall S. The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro. Biochem Biophys Res Commun. 1993 Jun 30;193(3):821–826. doi: 10.1006/bbrc.1993.1699. [DOI] [PubMed] [Google Scholar]
  35. Lorenzo J. A., Raisz L. G. Divalent cation ionophores stimulate resorption and inhibit DNA synthesis in cultured fetal rat bone. Science. 1981 Jun 5;212(4499):1157–1159. doi: 10.1126/science.6785885. [DOI] [PubMed] [Google Scholar]
  36. Löwik C. W., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O. L., Aarden L. A., Papapoulos S. E. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun. 1989 Aug 15;162(3):1546–1552. doi: 10.1016/0006-291x(89)90851-6. [DOI] [PubMed] [Google Scholar]
  37. McSheehy P. M., Chambers T. J. Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption. Endocrinology. 1986 Oct;119(4):1654–1659. doi: 10.1210/endo-119-4-1654. [DOI] [PubMed] [Google Scholar]
  38. Murrills R. J., Dempster D. W. The effects of stimulators of intracellular cyclic AMP on rat and chick osteoclasts in vitro: validation of a simplified light microscope assay of bone resorption. Bone. 1990;11(5):333–344. doi: 10.1016/8756-3282(90)90089-h. [DOI] [PubMed] [Google Scholar]
  39. Ohmori Y., Hamilton T. A. Cell type and stimulus specific regulation of chemokine gene expression. Biochem Biophys Res Commun. 1994 Jan 28;198(2):590–596. doi: 10.1006/bbrc.1994.1086. [DOI] [PubMed] [Google Scholar]
  40. Ohsaki Y., Takahashi S., Scarcez T., Demulder A., Nishihara T., Williams R., Roodman G. D. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology. 1992 Nov;131(5):2229–2234. doi: 10.1210/endo.131.5.1425421. [DOI] [PubMed] [Google Scholar]
  41. Partridge N. C., Alcorn D., Michelangeli V. P., Ryan G., Martin T. J. Morphological and biochemical characterization of four clonal osteogenic sarcoma cell lines of rat origin. Cancer Res. 1983 Sep;43(9):4308–4314. [PubMed] [Google Scholar]
  42. Passeri G., Girasole G., Jilka R. L., Manolagas S. C. Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology. 1993 Aug;133(2):822–828. doi: 10.1210/endo.133.2.8393776. [DOI] [PubMed] [Google Scholar]
  43. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G. A., Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994 Mar 1;13(5):1189–1196. doi: 10.1002/j.1460-2075.1994.tb06368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Raisz L. G., Trummel C. L., Simmons H. Induction of bone resorption in tissue culture. Prolonged response after brief exposure to parathyroid hormone or 25-hydroxycholecalciferol. Endocrinology. 1972 Mar;90(3):744–751. doi: 10.1210/endo-90-3-744. [DOI] [PubMed] [Google Scholar]
  45. Reid I. R., Lowe C., Cornish J., Gray D. H., Skinner S. J. Adenylate cyclase blockers dissociate PTH-stimulated bone resorption from cAMP production. Am J Physiol. 1990 Apr;258(4 Pt 1):E708–E714. doi: 10.1152/ajpendo.1990.258.4.E708. [DOI] [PubMed] [Google Scholar]
  46. Reid L. R., Lowe C., Cornish J., Skinner S. J., Hilton D. J., Willson T. A., Gearing D. P., Martin T. J. Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology. 1990 Mar;126(3):1416–1420. doi: 10.1210/endo-126-3-1416. [DOI] [PubMed] [Google Scholar]
  47. Rodan G. A., Martin T. J. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. Calcif Tissue Int. 1981;33(4):349–351. doi: 10.1007/BF02409454. [DOI] [PubMed] [Google Scholar]
  48. Roodman G. D. Interleukin-6: an osteotropic factor? J Bone Miner Res. 1992 May;7(5):475–478. doi: 10.1002/jbmr.5650070502. [DOI] [PubMed] [Google Scholar]
  49. Roodman G. D., Kurihara N., Ohsaki Y., Kukita A., Hosking D., Demulder A., Smith J. F., Singer F. R. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992 Jan;89(1):46–52. doi: 10.1172/JCI115584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sahni M., Guenther H. L., Fleisch H., Collin P., Martin T. J. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest. 1993 May;91(5):2004–2011. doi: 10.1172/JCI116422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Sato M., Grasser W. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy. J Bone Miner Res. 1990 Jan;5(1):31–40. doi: 10.1002/jbmr.5650050107. [DOI] [PubMed] [Google Scholar]
  52. Taga T., Kawanishi Y., Hardy R. R., Hirano T., Kishimoto T. Receptors for B cell stimulatory factor 2. Quantitation, specificity, distribution, and regulation of their expression. J Exp Med. 1987 Oct 1;166(4):967–981. doi: 10.1084/jem.166.4.967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Tamura T., Udagawa N., Takahashi N., Miyaura C., Tanaka S., Yamada Y., Koishihara Y., Ohsugi Y., Kumaki K., Taga T. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11924–11928. doi: 10.1073/pnas.90.24.11924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Yoneda T., Nakai M., Moriyama K., Scott L., Ida N., Kunitomo T., Mundy G. R. Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma. Cancer Res. 1993 Feb 15;53(4):737–740. [PubMed] [Google Scholar]
  55. Zhu J. F., Valente A. J., Lorenzo J. A., Carnes D., Graves D. T. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res. 1994 Jul;9(7):1123–1130. doi: 10.1002/jbmr.5650090721. [DOI] [PubMed] [Google Scholar]
  56. al-Humidan A., Ralston S. H., Hughes D. E., Chapman K., Aarden L., Russell R. G., Gowen M. Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariae. J Bone Miner Res. 1991 Jan;6(1):3–8. doi: 10.1002/jbmr.5650060103. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES